Terapia con células madre e insuficiencia cardiaca: aspectos éticos
- Autores: Rienzi Díaz-Navarro, Carmen Perez-Terzic
- Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 147, Nº. 6, 2019, págs. 787-789
- Idioma: español
- Títulos paralelos:
- Ethics of stem cell therapy for heart failure
- Enlaces
-
Resumen
Heart failure is one of the first diseases in which stem cells were used for regenerative medicine. Since 2001, many publications have shown that stem cell therapy has the potential to mitigate heart diseases, but there is no solid scientific evidence to fully support its clinical application at present. The future of regenerative medicine requires validated clinical trials with standardized platforms and transdisciplinary efforts to enable the development of safe and effective regenerative therapies to protect patients and to promote the ethical application of this new and highly promising therapy. Doctors and scientists have a responsibility to discuss with patients the current reality of regenerative therapies. They also have a responsibility to discourage the indiscriminate and commercial use of these therapies, which are sometimes based on false hopes, since their inappropriate use can harm vulnerable patients as well as research efforts. Although regenerative medicine may be the medicine of the future and might bring the hope of cure for chronic diseases, it is not yet ready for its wide clinical application.
